In this recording from our virtual webinar on the American College of Rheumatology’s new Lupus Nephritis Treatment Guidelines, learn more about evidence-based, expert recommendations for adults and ...

Fate Therapeutics FATE recently announced that the FDA has granted the Regenerative Medicine Advanced Therapy (RMAT) ...

The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro (obinutuzumab) as a treatment for lupus nephritis, with a decision expected in ...